As the new year gets underway we would like to share some changes to our Editorial Board.
Editorial Board Retirements
After 6 years with Natural Product Reports we are very sorry to see Professors David L. Jakeman and Stefan Schulz step down from their roles on the Editorial Board. We would like to take this opportunity to thank both David and Stefan for all of their time and effort over the past 6 years, helping to make the journal the success it is today. Thank you!
However, we are pleased to say that although David and Stefan may be leaving the Editorial Board they will not be leaving us entirely. Both are now members of the Advisory Board for the journal and we look forward to continue working with them in the future in this new role.
New Editorial Board Members
We would also like to take this opportunity to welcome some new faces to the Natural Product Reports family.
Professor Giovanni Appendino, Universita del Piemonte Orientale, Italy.
Professor Giovanni Appendino did his Laurea Degree at the University of Torino (Italy) in 1979. He did Post-Laurea work at the Laboratory of Organic Synthesis, University of Gent (Belgium) with Prof. Pierre De Clercq. He has been a Full Professor of Organic Chemistry at the Università del Piemonte Orientale, Department of Pharmaceutical Sciences, Novara (Italy), since 2000.
Research activity in his laboratories takes inspiration from plant natural products to address problems in various realms of biomedical investigation, from pharmacology and nutrition (new drug leads and health-promoting dietary ingredients) to organic/medicinal chemistry (new synthetic methodologies and optimization of natural product drug leads) and cell biology (novel mechanisms of activity).
Professor Mark Brönstrup, Helmholtz Centre for Infection Research, Germany
Mark Brönstrup studied Chemistry at the Philipps-Universität Marburg and at the Imperial College in London. In 1999 he received his doctorate from the Technical University Berlin in Organic Chemistry. After his graduation, he worked from 2000 to 2004 as a laboratory head for Mass Spectrometry at Aventis, complemented by a research sabbatical in 2003 at Harvard Medical School. From 2005 to 2010 he led the Natural Product Sciences section at Sanofi-Aventis in Frankfurt with the goal of discovering leads from natural sources and optimising them to clinical candidates. He dealt with translational research projects from 2010 to 2013 as a section head for Biomarkers & Diagnostics in the Diabetes Division, and a domain head for Biomarkers, Bioimaging & Biological Assays at Sanofi. Since December 2013, he heads the department Chemical Biology at the Helmholtz Centre for Infection Research; additionally, he holds a Professorship (W3) at the Leibniz Universität Hannover.
Mark Brönstrup’s research uses chemical biology tools to understand mechanisms for the treatment of infectious diseases.
Professors Appendino and Brönstrup began their roles as Editorial Board members from January 2015, and we look forward to working closely with them over the coming months and years.